(Reuters Health)—Among a group of New York patients with rheumatic diseases who received a SARS-CoV-2 vaccine, nearly one in six experienced disease flares after getting their shots, a new study finds.1 A survey of more than 1,100 patients who had received at least one vaccine dose revealed that 14.9% experienced flares. Among the 654 who…
Lungs Are Particularly Vulnerable in Patients with Systemic Rheumatic Disease
In an observational study, physicians found that systemic rheumatic disease exacerbation and treatment-related infections were often related to the lungs…